Toxicity Studies

Chapter
Part of the Progress in Drug Research book series (PDR, volume 71)

Abstract

Toxicity studies in the animal models are done to determine the dose level recommended for the treatment of disease as drug. This guideline enables the characterization of adverse effects following repeated daily inhalation exposure to a test. This chapter includes oral and dermal toxicity studies which are discussed as per OECD guidelines. Both acute and subacute toxicity studies are given special emphasis.

Keywords

Plant Extract Toxicity Study Aspiration Pneumonia Guidance Document Volume Selection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Bonnichsen, M., Dragsted, N., & Hansen, A.K. (2005). The welfare impact of gavaging laboratory rats. Animal Welfare, 14, 223–227.Google Scholar
  2. British Toxicology Society Working Party on Toxicity. (1984). Special report: A new approach to the classification of substances and preparations on the basis of their acute toxicity. Human Toxicology, 3, 85–92.CrossRefGoogle Scholar
  3. Karl-Heinz, D., Robin, H., David, M., Rudolf, P., Yvon, R., David, S., et al. (2001). A good practice guide to the administration of substances and removal of blood, including routes and volumes. Journal of Applied Toxicology, 21, 15–23.CrossRefGoogle Scholar
  4. Nebendahl, K. (2000). In G. Krinke (Ed.), The laboratory rat (pp. 463–483). London: Academic Press.CrossRefGoogle Scholar
  5. OECD. (2000a). Guidance document on the recognition, assessment and use of clinical signs as humane endpoints for experimental animals used in safety evaluation. Environmental Health and Safety Monograph Series on Testing and Assessment No. 19, ENV/JM/MONO (2000)7. Paris: OECD.Google Scholar
  6. OECD. (2000b). Guidance document on acute oral toxicity. Environmental Health and Safety Monograph Series on Testing and Assessment No. 24.Google Scholar
  7. OECD. (2000c). Guidance document on the recognition, assessment and use of clinical signs as humane end points for experimental animals used in safety evaluation. Environmental Health and Safety Monograph Series on Testing and Assessment No. 19.Google Scholar
  8. OECD (Organization for Economic Co-operation and Development) guidelines for testing of chemicals 402, 1987, pp. 1–7.Google Scholar
  9. OECD (Organization for Economic Co-operation and Development) revised draft guidelines 423. OECD Guidelines for the testing of chemicals, 2001.Google Scholar
  10. OECD guidelines for the testing of chemicals. TG 412, Subacute Inhalation Toxicity: 28-Day Study, 1981.Google Scholar
  11. Stallard, N., & Whitehead, A. (1995). Reducing numbers in the fixed-dose procedure. Human and Experimental Toxicology, 14, 315–323.CrossRefPubMedGoogle Scholar
  12. Stallard, N., Whitehead, A., & Ridgeway, P. (2002). Statistical evaluation of the revised fixed dose procedure. Human and Experimental Toxicology, 21, 183–196.Google Scholar
  13. Van den Heuvel, M. J., Clark, D. G., Fielder, R. J., Koundakjian, P. P., Oliver, G. J. A., Pelling, D., et al. (1990). The international validation of a fixed-dose procedure as an alternative to the classical LD50 test. Food and Chemical Toxicology, 28, 469–482.CrossRefPubMedGoogle Scholar
  14. Van den Heuvel, M. J., Dayan, A. D., & Shillaker, R. O. (1987). Evaluation of the BTS approach to the testing of substances and preparations for their acute toxicity. Human Toxicology, 6, 279–291.CrossRefPubMedGoogle Scholar
  15. Whitehead, A., & Curnow, R. N. (1992). Statistical evaluation of the fixed-dose procedure. Food and Chemical Toxicology, 30, 313–324.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Bioprospecting Laboratory, Department of BotanyBharathiar UniversityCoimbatoreIndia

Personalised recommendations